Compagnie Lombard Odier SCmA’s MacroGenics MGNX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$17K	–	550
2020 Q1	$17K	Hold	3,000	–	–	﹤0.01%	416
2019 Q4	$33K	Buy	3,000 +1,200	+67%	+$11.9K	﹤0.01%	387
2019 Q3	$23K	Buy	+1,800	New	+$25.9K	﹤0.01%	413
2017 Q1	–	Sell	-2,400	Closed	-$49K	–	801
2016 Q4	$49K	Hold	2,400	–	–	﹤0.01%	606
2016 Q3	$72K	Hold	2,400	–	–	﹤0.01%	632
2016 Q2	$65K	Hold	2,400	–	–	﹤0.01%	626
2016 Q1	$45K	Hold	2,400	–	–	﹤0.01%	728
2015 Q4	$74K	Hold	2,400	–	–	﹤0.01%	641
2015 Q3	$51K	Hold	2,400	–	–	﹤0.01%	601
2015 Q2	$91K	Hold	2,400	–	–	﹤0.01%	570
2015 Q1	$75K	Buy	+2,400	New	+$81.3K	﹤0.01%	715

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Compagnie Lombard Odier SCmA's MGNX Position: Q2 2020 in Review

Compagnie Lombard Odier SCmA sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 3,000 shares — an estimated $17K sold.

Compagnie Lombard Odier SCmA first reported a position in MGNX in Q1 2015 and held it in 11 quarters. The position peaked at $91K in Q2 2015. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

Compagnie Lombard Odier SCmA reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 3,000 MacroGenics shares in Q2 2020, an estimated $17K.
Compagnie Lombard Odier SCmA first reported a position in MacroGenics in Q1 2015 and held it in 11 quarters.
Compagnie Lombard Odier SCmA's MacroGenics position peaked at $91K in Q2 2015.
137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2020, filed 14 Aug 2020.